Trial Profile
The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis: a Phase 2, Randomized, Double-blind Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs CELEXT 07 (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors 9305-9954 Quebec
- 04 Apr 2019 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified April 2017).
- 24 Apr 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
- 24 Apr 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.